The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (113.57) USD. With the latest stock price at 8.03 USD, the upside of Regenxbio Inc based on DCF is -1514.3%.
Based on the latest price of 8.03 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1514.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 7.1% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (513.12) - (66.81) | (113.57) |
| Upside | -6490.0% - -932.1% | -1514.3% |